Leff JA - Search Results

1

Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis.

Valeyre D, Albera C, Bradford WZ, Costabel U, King TE Jr, Leff JA, Noble PW, Sahn SA, du Bois RM. Valeyre D, et al. Among authors: leff ja. Respirology. 2014 Jul;19(5):740-7. doi: 10.1111/resp.12297. Epub 2014 May 18. Respirology. 2014. PMID: 24836849 Free PMC article.

2

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.

Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Noble PW, et al. Among authors: leff ja. Eur Respir J. 2016 Jan;47(1):243-53. doi: 10.1183/13993003.00026-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647432 Free PMC article.

3

6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.

du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. du Bois RM, et al. Among authors: leff ja. Eur Respir J. 2014 May;43(5):1421-9. doi: 10.1183/09031936.00131813. Epub 2013 Dec 5. Eur Respir J. 2014. PMID: 24311766 Free article. Clinical Trial.

4

All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.

King TE Jr, Albera C, Bradford WZ, Costabel U, du Bois RM, Leff JA, Nathan SD, Sahn SA, Valeyre D, Noble PW. King TE Jr, et al. Among authors: leff ja. Am J Respir Crit Care Med. 2014 Apr 1;189(7):825-31. doi: 10.1164/rccm.201311-1951OC. Am J Respir Crit Care Med. 2014. PMID: 24476390 Free article.

5

Selection of clinically meaningful primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis.

Bradford WZ, Cohen AH, Leff JA. Bradford WZ, et al. Among authors: leff ja. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1269-70. doi: 10.1164/rccm.201204-0770LE. Am J Respir Crit Care Med. 2013. PMID: 23725618 No abstract available.

6

Cavitary lung disease with skin lesions.

Leff JA, King TE Jr. Leff JA, et al. Chest. 1989 Feb;95(2):457-8. doi: 10.1378/chest.95.2.457. Chest. 1989. PMID: 2914498 No abstract available.

7

Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.

White ES, Brown KK, Collard HR, Conoscenti CS, Cosgrove GP, Flaherty KR, Leff JA, Martinez FJ, Roman J, Rose D, Violette S, Kaminski N. White ES, et al. Among authors: leff ja. Ann Am Thorac Soc. 2014 Oct;11(8):1171-5. doi: 10.1513/AnnalsATS.201406-289OI. Ann Am Thorac Soc. 2014. PMID: 25167209 Free PMC article. Review.

8

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.

Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM. Barnes N, et al. Among authors: leff ja. Respir Med. 2001 May;95(5):379-86. doi: 10.1053/rmed.2001.1052. Respir Med. 2001. PMID: 11392579 Free article. Review.

9

Coexistence of primary biliary cirrhosis and sarcoidosis.

Leff JA, Ready JB, Repetto C, Goff JS, Schwarz MI. Leff JA, et al. West J Med. 1990 Oct;153(4):439-41. West J Med. 1990. PMID: 2244380 Free PMC article. No abstract available.

10

Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats.

Leff JA, Wilke CP, Hybertson BM, Shanley PF, Beehler CJ, Repine JE. Leff JA, et al. Am J Physiol. 1993 Nov;265(5 Pt 1):L501-6. doi: 10.1152/ajplung.1993.265.5.L501. Am J Physiol. 1993. PMID: 8238538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters